Pricing

Vericel

‌

Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Dominick Colangelo

President & CEO

Collapse

Joe Mara

CFO

Jonathan Hopper

Chief Medical Officer

Sean Flynn

SVP, General Counsel & Secretary

Mike Halpin

SVP, Quality & Regulatory Affairs

Patrick Fowler

SVP, Corporate Development & Strategy

Doug Kennedy

SVP, Operations

Heidi Hassen

SVP, Human Resources

Demet Durak

Senior Executive Assistant To The CEO

Karen Mahoney

Chief Human Resources Officer

Board & advisors

Chairman

Director

Director

Member Of The Board

Director

Director

Teams

+25

Sales and Marketing

29 people · 0 jobs

+10

Clinical and Medical Affairs

14 people · 0 jobs

Operations and Development Team

11 people · 0 jobs

Quality and Regulatory

8 people · 0 jobs

Directors Team

9 people · 0 jobs

Finance and Accounting

7 people · 0 jobs

Offices

HQ
55 people · 0 jobs
JC
CO
+51

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

161 followers

Regeneron

132 followers

Illumina

79 followers

Agilent Technologies

82 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

Explore companies